These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21111736)

  • 1. Statins--increasing or reducing the risk of Parkinson's disease?
    Dolga AM; Culmsee C; de Lau L; Winter Y; Oertel WH; Luiten PG; Eisel UL
    Exp Neurol; 2011 Mar; 228(1):1-4. PubMed ID: 21111736
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholesterol levels, statins, and Parkinson's disease.
    Rizvi Z; Hilas O
    Consult Pharm; 2008 May; 23(5):408, 411. PubMed ID: 18540794
    [No Abstract]   [Full Text] [Related]  

  • 3. Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease.
    Herrero MT; Levy R; Ruberg M; Javoy-Agid F; Luquin MR; Agid Y; Hirsch EC; Obeso JA
    Adv Neurol; 1996; 69():209-16. PubMed ID: 8615130
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxins, genetics, and Parkinson's disease: the role of N-acetyltransferase 2.
    Bandmann O; Vaughan J; Holmans PA; Marsden CD; Wood NW
    Adv Neurol; 1999; 80():199-204. PubMed ID: 10410722
    [No Abstract]   [Full Text] [Related]  

  • 5. [Search for the cause of Parkinson's disease].
    Langston JW
    Arch Neurobiol (Madr); 1991; 54(6):264-71. PubMed ID: 1811457
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins, cholesterol, Co-enzyme Q10, and Parkinson's disease.
    Lieberman A; Lyons K; Levine J; Myerburg R
    Parkinsonism Relat Disord; 2005 Mar; 11(2):81-4. PubMed ID: 15734664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.
    de Lau LM; Stricker BH; Breteler MM
    Mov Disord; 2007 Oct; 22(13):1985. PubMed ID: 17557354
    [No Abstract]   [Full Text] [Related]  

  • 8. Parkinson's disease.
    Lieberman AN
    Compr Ther; 1986 Mar; 12(3):25-9. PubMed ID: 3486090
    [No Abstract]   [Full Text] [Related]  

  • 9. Future strategies for the treatment of Parkinson's disease.
    Fahn S
    Adv Neurol; 1993; 60():636-40. PubMed ID: 8420202
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary prevention of cardiovascular disease with statins: cautionary notes.
    Goldstein MR; Mascitelli L; Pezzetta F
    QJM; 2009 Nov; 102(11):817-20. PubMed ID: 19620217
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinson's disease, pesticides and individual vulnerability.
    Paolini M; Sapone A; Gonzalez FJ
    Trends Pharmacol Sci; 2004 Mar; 25(3):124-9. PubMed ID: 15019266
    [No Abstract]   [Full Text] [Related]  

  • 12. Case studies in the advancement of Parkinson's disease.
    Frei K; Truong DD; Wolters E
    CNS Spectr; 2008 Dec; 13(12 Suppl 18):1-6. PubMed ID: 19179948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin usage, vascular diagnosis and vascular risk factors in Parkinson's disease.
    Cheng KK; Swallow DM; Grosset KA; Grosset DG
    Scott Med J; 2017 Aug; 62(3):104-109. PubMed ID: 28836927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging perspectives in Parkinson's disease.
    Lieberman A
    Neurology; 1992 Apr; 42(4 Suppl 4):5-7. PubMed ID: 1584431
    [No Abstract]   [Full Text] [Related]  

  • 15. Does fluoxetine aggravate Parkinson's disease? A pilot prospective study.
    Montastruc JL; Fabre N; Blin O; Senard JM; Rascol O; Rascol A
    Mov Disord; 1995 May; 10(3):355-7. PubMed ID: 7651460
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroprotective therapy for Parkinson's disease.
    Koller WC
    Exp Neurol; 1997 Mar; 144(1):24-8. PubMed ID: 9126147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of Parkinson's disease.
    Riederer P; Lange KW
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):295-300. PubMed ID: 1623255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease. Fresh factors to consider.
    Snyder SH
    Nature; 1991 Mar; 350(6315):195. PubMed ID: 2005976
    [No Abstract]   [Full Text] [Related]  

  • 19. [Etiology and therapy of Parkinson's syndrome and related pharmacological concepts shown in experimental models].
    Oehme P; Schwarz K
    Dtsch Gesundheitsw; 1966 Apr; 21(17):792-8. PubMed ID: 5929188
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of new pharmacological approaches in Parkinson's disease.
    Carlsson A
    Adv Neurol; 1987; 45():513-8. PubMed ID: 3493631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.